Hyung Heon KimCEO at MetaVia TherapeuticsSpeaker
Agenda Sessions
Exploring DA-1726, a Novel 3:1 Ratio GLP-1 and Glucagon Dual Receptor Agonist
, 13:50View Session
This site is part of the Informa Connect Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Exploring DA-1726, a Novel 3:1 Ratio GLP-1 and Glucagon Dual Receptor Agonist